Evidence map›Paper›PMID 38162949›Full record

ArticleJournal of blood medicine2023

Predictors of Intensive Care Admission Among Adult Patients with Sickle Cell Disease in Eastern Province of Saudi Arabia.

Mortadah Alsalman, Zaenb Alsalman, Hussain Abduljaleel Alkhalifa, Aman N Alfaraj, Ali Alkhalifah, Qasem Almulihi

Abstract read
In one paragraph

Article in Journal of blood medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mortadah AlsalmanDepartment of Medicine, College of Medicine, King Faisal University, Alahsa, Saudi Arabia.ORCID 0000-0003-3975-5550
Zaenb AlsalmanDepartment of Family and Community Medicine, College of Medicine, King Faisal University, Alahsa, Saudi Arabia.ORCID 0000-0002-1008-7977
Hussain Abduljaleel AlkhalifaDepartment of Medicine, King Fahad Specialist Hospital, Dammam, Saudi Arabia.ORCID 0000-0002-4709-5030
Aman N AlfarajDepartment of Medicine, King Fahad Specialist Hospital, Dammam, Saudi Arabia.
Ali AlkhalifahEmergency Department, Eastern Health Cluster, Dammam, Saudi Arabia.ORCID 0000-0002-6744-2626
Qasem AlmulihiEmergency Department, King Fahad University Hospital, Al Khobar, Saudi Arabia.ORCID 0000-0001-6341-0910

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Sickle cell disease (SCD) comprises a complex group of hematologic disorders that are collectively the most common monogenic disorder and are associated with increased risk of intensive care unit admission (ICU). The purpose of this study is to investigate factors that predict admission of adult patients with SCD to the ICU. Patients and Methods: This was a cross-sectional study that enrolled adult patients with SCD from Saudi Arabia. Results: A total of 107 patients with SCD, with a median age 31.9±12.1 years, were evaluated retrospectively. Regarding predictors of ICU admission, patients who indicated a history of blood transfusions were at 8.047-fold higher risk of ICU admission (OR=8.047; 95% CI=2.392-27.07; Conclusion: SCD is a multi-systemic disease associated with increased morbidity and mortality. Recognition of high-risk features in patients helps to eliminate subjectivity in ICU referral decision. Frequent hospitalization and emergency visits, multiple blood transfusions, and elevated white blood cell count were significantly associated with a higher rate of ICU admission despite hydroxyurea usage.

Indexed as

hydroxyureaintensive care unitsickle cell disease

Identifiers

PMID38162949
PMCPMC10757811

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.